Osvaren (Magnesium Carbonate Heavy, Calcium Acetate)

Magnesium carbonate heavy, the active ingredient in Osvaren, is a mineral supplement presented as a solid oral formulation for systemic use. It is combined with calcium acetate to support electrolyte balance and bone health in patients requiring mineral supplementation. GNH USA supplies Osvaren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Osvaren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Osvaren contains magnesium carbonate heavy and calcium acetate, which act on mineral metabolism pathways. It is used in clinical practice for: - Hypocalcemia: Helps restore normal calcium levels in patients with low serum calcium. - Hypomagnesemia: Provides magnesium to correct low magnesium concentrations. - Osteoporosis prevention: Contributes to bone mineral density maintenance in at‑risk populations. - Chronic kidney disease management: Assists in phosphate binding and mineral balance in CKD patients. - Post‑surgical recovery: Supports electrolyte repletion during postoperative care.

Osvaren may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Diarrhea: Loose stools may occur, especially with higher magnesium loads. - Abdominal discomfort: Cramping or bloating is reported. - Nausea: Mild nausea can accompany oral intake. - Flatulence: Increased gas production is possible. - Constipation: Occasionally observed with calcium acetate.

Serious or Rare Side Effects: - Hypermagnesemia: Elevated magnesium levels can lead to cardiac arrhythmias. - Hypercalcemia: Excess calcium may cause kidney stones or vascular calcification. - Severe allergic reaction: Rash, itching, swelling, or anaphylaxis. - Electrolyte imbalance: Significant shifts in serum electrolytes requiring medical intervention.

When using Osvaren, consider the following safety measures: - Renal function assessment: Evaluate kidney performance before initiating therapy. - Serum electrolyte monitoring: Regularly check calcium and magnesium levels during treatment. - Gastrointestinal tolerance: Assess for diarrhea or constipation and adjust dosage if needed. - Drug interaction review: Verify concomitant medications that affect electrolyte balance. - Pregnancy and lactation: Use only if clearly needed, after risk‑benefit evaluation. - Store at below 25°C: Keep in the original container, protect from moisture and direct sunlight.

Osvaren can interact with several medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Calcium channel blockers: May potentiate hypotensive effects. - Digoxin: Elevated magnesium can increase risk of digoxin toxicity. - Bisphosphonates: Calcium acetate may reduce oral absorption of bisphosphonates.

Moderate Interactions (Monitor Closely): - Loop diuretics: Can amplify magnesium loss, necessitating closer electrolyte monitoring. - Proton pump inhibitors: May alter calcium absorption dynamics. - Antibiotics (tetracyclines, quinolones): Calcium can chelate these agents, reducing their effectiveness.